Here are some frequently asked questions.
90
%
of drug candidates still fail in human trials.
What is R3 Bio's Mission?
R3 Bio develops cell-based research platforms using cellular reprogramming, human stem-cell-derived systems, and advanced analytical methods. Our near-term focus is narrow and executable: experimental cell-culture systems and rigorous model validation that serve as New Approach Methodologies (NAMs) to advance the 3Rs: Replacement, Reduction, and Refinement of animal testing.
Where are we based?
San Francisco with an upcoming second location in Puerto Rico.
Recent Media Coverage
We noted recent sensational media coverage. Such attention is not encouraged by us. R3 Bio works with microscopic structures in cell culture. We do not produce the types of large scale structures envisioned in the media. We do not work with live primates.
Have you considered human applications?
R3 Bio would be excited by the future prospect of full-scale human organ fabrication. However, we view the science as currently not ready. We have no ongoing work in this area.
What do you really do?
In the past few years, we created a few basic technologies in molecular cell biology. These could be applied in different ways. We think that reducing and replacing some of the current drug testing done on animals, would be a realistic first application, but even that is not fully ready yet.
We do not currently apply those to any human medical problems, such as organ production. We believe that further unknown breakthroughs would be needed for such highly dramatic applications.